We present a case of immune-mediated diabetes mellitus, diagnosed in pregnancy upon presentation with diabetic ketoacidosis, found to have normal glucose control postpartum.
A 28-year-old medically uncomplicated G1P0 presented in diabetic ketoacidosis at 28.2 weeks gestation. Workup for pancreatic autoantibodies revealed indeterminate anti-islet cell antibodies and positive anti-glutamic acid antibodies. She was stabilized with intravenous fluids and insulin, and transitioned to long and short acting subcutaneous insulin. Her insulin requirements decreased over the course of her pregnancy. Spontaneous vaginal delivery occurred at 37 weeks. Her postpartum glucose control was normal without re-initiation of insulin.
The diagnosis of diabetic ketoacidosis during pregnancy should prompt further investigation into an underlying diagnosis of immune mediated diabetes. These patients should be followed closely in the postpartum period.
Research funding: None declared.
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
Competing interests: Authors state no conflict of interest.
Informed consent: Informed consent was obtained from all individuals included in this study.
Ethical approval: Not applicable.
1. Sacks, DA, Hadden, DR, Maresh, M. Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care 2012;35:526–8. https://doi.org/10.2337/dc11-1641.Search in Google Scholar
2. Fuchtenbusch, M, Ferber, K, Standl, E, Ziegler, AG. Prediction of type 1 diabetes postpartum in patients with gestational diabetes mellitus by combined islet cell autoantibody screening: a prospective multicenter study. Diabetes 1997;46:1459–67. https://doi.org/10.2337/diabetes.46.9.1459.Search in Google Scholar
3. Lapolla, A, Dalfra, MG, Fedele, D. Diabetes related autoimmunity in gestational diabetes mellitus: is it important? Nutr Metabol Cardiovasc Dis 2009;19:674–82. https://doi.org/10.1016/j.numecd.2009.04.004.Search in Google Scholar
4. Buschard, K, Hougaard, P, Molsted-Pedersen, L, Kuhl, C. Type 1 (insulin-dependent) diabetes mellitus diagnosed during pregnancy: a clinical and prognostic study. Diabetologia 1990;33:31–5. https://doi.org/10.1007/bf00586458.Search in Google Scholar
5. Wucher, H, Lepercg, J, Timsit, J. Onset of autoimmune type 1 diabetes during pregnancy: prevalence and outcomes. Best Pract Res Clin Endocrinol Metabol 2010;24:617–24. https://doi.org/10.1016/j.beem.2010.06.002.Search in Google Scholar
6. Bo, S, Menato, G, Pinach, S, Signorile, A, Bardelli, C, Lezo, A, et al.. Clinical characteristics and outcome of pregnancy in women with gestational hyperglycaemia with and without antibodies to beta-cell antigens. Diabet Med 2003;20:64–8. https://doi.org/10.1046/j.1464-5491.2003.00721.x.Search in Google Scholar
7. Jarvela, IY, Juutinen, J, Koskela, P, Hartikainen, AL, Kulmala, P, Knip, M, et al.. Gestational diabetes identifies women at risk for permanent type 1 and type 2 diabetes in fertile age: predictive role of autoantibodies. Diabetes Care 2006;29:607–12. https://doi.org/10.2337/diacare.29.03.06.dc05-1118.Search in Google Scholar
8. Icani, M, Baroni, MG, Cossu, E. Testing for type 1 diabetes autoantibodies in gestational diabetes mellitus (GDM): is it clinically useful? BMC Endocr Disord 2019;19:44.10.1186/s12902-019-0373-4Search in Google Scholar PubMed PubMed Central
9. Cossu, E, Incani, M, Pani, MG, Gattu, G, Serafini, C, Strazzera, A, et al.. Presence of diabetes-specific autoimmunity in women with gestational diabetes mellitus (GDM) predicts impaired glucose regulation at follow-up. J Endocrinol Invest 2018;41:1061–8. https://doi.org/10.1007/s40618-018-0830-3.Search in Google Scholar
10. Loebner, K, Knopff, A, Baumgarten, A, Mollenhauer, U, Marienfeld, S, Garrido-Franco, M, et al.. Predictors of postpartum diabetes in women with gestational diabetes mellitus. Diabetes 2006;55:792–7.10.2337/diabetes.55.03.06.db05-0746Search in Google Scholar PubMed
11. Nilsson, C, Ursing, D, Torn, C, Aberg, A, Landin-Olsson, M. Presence of GAD antibodies during gestational diabetes mellitus predicts type 1 diabetes. Diabetes Care 2007;30:1968–71. https://doi.org/10.2337/dc07-0157.Search in Google Scholar
12. Catalano, PM, Tyzbir, ED, Sims, EA. Incidence and significance of islet cell antibodies in women with previous gestational diabetes. Diabetes Care 1990;13:478–82. https://doi.org/10.2337/diacare.13.5.478.Search in Google Scholar
13. Damm, P, Kuhl, C, Buschard, K, Jakobsen, BK, Svejgaard, A, Sodoyez-Goffaux, F, et al.. Prevalence and predictive value of islet cell antibodies and insulin autoantibodies in women with gestational diabetes. Diabet Med 1994;1:558–63. https://doi.org/10.1111/j.1464-5491.1994.tb02035.x.Search in Google Scholar
14. Zampetti, S, Campagna, G, Tiberti, C, Songini, M, Arpi, ML, De Simone, G, et al.. High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7). Eur J Endocrinol 2014;171:697–704. https://doi.org/10.1530/eje-14-0342.Search in Google Scholar
15. Mauricio, D, Corcoy, R, Codina, M, Balsells, M, Puig Domingo, M, Pou, JM, et al.. Islet cell antibodies identify a subset of gestational diabetic women with higher risk of developing diabetes mellitus shortly after pregnancy. Diabetes Nutr Metab 1992;5:237–41.Search in Google Scholar
16. Poola-Kella, S, Steinman, RA, Mesmar, B, Malek, R. Gestational diabetes mellitus: post-partum risk and follow up. Rev Recent Clin Trials 2018;13:5–14. https://doi.org/10.2174/1574887112666170911124806.Search in Google Scholar
17. Castling, ZA, Farrell, T. An analysis of demographic and pregnancy outcome data to explain non-attendance for postpartum glucose testing in women with gestational diabetes mellitus: why are patients missing follow-up? Obstet Med 2019;12:85–9. https://doi.org/10.1177/1753495x18797201.Search in Google Scholar
18. Butalia, S, Donovan, L, Savu, A, Johnson, J, Edwards, A, Kaul, P. Postpartum diabetes testing rates after gestational diabetes mellitus in Canadian women: a population-based study. Can J Diabetes 2017;41:613–20. https://doi.org/10.1016/j.jcjd.2016.12.013.Search in Google Scholar
19. Van Ryswyk, EM, Middleton, PF, Hague, WM, Crowther, CA. Women’s views on postpartum testing for type 2 diabetes after gestational diabetes: six month follow-up to the DIAMIND randomised controlled trial. Prim Care Diabetes 2016;10:91–102. https://doi.org/10.1016/j.pcd.2015.07.003.Search in Google Scholar
20. Balaji, B, Ranjit Mohan, A, Rajendra, P, Mohan, D, Ram, U, Viswanathan, M. Gestational diabetes mellitus postpartum follow-up testing: challenges and solutions. Can J Diabetes 2019;43:641–6. https://doi.org/10.1016/j.jcjd.2019.04.011.Search in Google Scholar
21. Hamel, MS, Werner, EF. Interventions to improve rate of diabetes testing postpartum in women with gestational diabetes mellitus. Curr Diabetes Rep 2017;17:7. https://doi.org/10.1007/s11892-017-0835-x.Search in Google Scholar
© 2021 Walter de Gruyter GmbH, Berlin/Boston